Safety and Efficacy of RK0202 in Oral Mucositis [clinicaltrials:NCT00230191]
Safety and Efficacy of RK0202 in Oral Mucositis [clinicaltrials:NCT00230191]
Bio2RDF identifier
NCT00230191
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00230191
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The primary objective o ...... is not allowed in the study.
brief title [clinicaltrials_vocabulary:brief-title]
Safety and Efficacy of RK0202 in Oral Mucositis
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
completion date [clinicaltrials_vocabulary:completion-date]
2005-12-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Approximately 42,000 ne ...... frequent hospitalizations.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-09-28T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
Head and Neck Cancer
Stomatitis
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2007-01-12T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct alias [clinicaltrials_vocabulary:nct-alias]
NCT00046956
nct id [clinicaltrials_vocabulary:nct-id]
NCT00230191
official title [clinicaltrials_vocabulary:official-title]
Phase II, Multicenter, Double- ...... Glands or Supraglottic Region
org study id [clinicaltrials_vocabulary:org-study-id]
RK:0202-02
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2003-01-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2005-10-01T00:00:00Z
identifier
clinicaltrials:NCT00230191
title
Safety and Efficacy of RK0202 in Oral Mucositis
@en
type
label
Safety and Efficacy of RK0202 in Oral Mucositis [clinicaltrials:NCT00230191]
@en